Addressing Common Patient Concerns

The maximum dose in patients with moderate

Related/similar drugs

Most, but not all, of these patients had underlying anatomic or vascular risk factors for development of NAION, including but not necessarily limited to: low cup to disc ratio (“crowded disc”), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia and smoking. It is not possible to determine whether these events are related directly to the use of PDE5 inhibitors, to the patient’s underlying vascular risk factors or anatomical defects, to a combination of these factors, or to other factors (see PRECAUTIONS, Information for Patients). Visual disturbances including vision loss (temporary or permanent), such as visual field defect, retinal vein occlusion, and reduced visual acuity, have also been reported rarely in post-marketing experience. It is not possible to determine whether these events are related directly to the use of LEVITRA. Seizure, seizure recurrence and transient global amnesia have been reported post-marketing in temporal association with LEVITRA.

What should I know about vardenafil before taking it?

Cases of sudden decrease or loss of hearing have been reported post-marketing in temporal association with the use of PDE5 inhibitors, including LEVITRA. In some cases, medical conditions and other factors were reported that may have also played a role in the otologic adverse events. In many cases, medical follow-up information was limited. It is not possible to determine whether these reported events are related directly to the use of LEVITRA, to the patient’s underlying risk factors for hearing loss, a combination of these factors, or to other factors (see PRECAUTIONS, Information for Patients). The maximum dose of LEVITRA for which human data are available is a single 120 mg dose administered to eight healthy male volunteers. hepatic impairment should not exceed 10 mg.

Medication	Typical Dose	Onset of Action	Duration	Common Side Effects	Price Range (approx.)
Levitra (20mg)	20mg	25-60 mins	Up to 5 hrs	Headache, flushing	$$$
Viagra (Sildenafil)	50-100mg	30-60 mins	4-6 hrs	Vision changes, headaches	$$
Cialis (Tadalafil)	10-20mg	30-60 mins	Up to 36 hrs	Muscle pain, headache	$$$$
Stendra (Avanafil)	50-200mg	15-30 mins	6 hrs	Flushing, nasal congestion	$$$

LEVITRA has not been evaluated in patients with severe hepatic

• The development of vardenafil was a significant advancement in ED treatment.
• It offered an alternative for patients who did not respond to or tolerate sildenafil.
• Its development involved extensive clinical research and safety testing.
• Ongoing pharmacovigilance continues to monitor its safety profile worldwide.
• Research into new formulations and applications for PDE5 inhibitors continues.
• The goal is always to improve patient outcomes, safety, and quality of life.

impairment (Child-Pugh C) (see CLINICAL

• Levitra 20mg is often prescribed for men aged 18 and above.
• It is available in tablet form for oral administration.
• Common side effects include headache, flushing, and nasal congestion.
• Alcohol consumption can reduce Levitra's effectiveness and increase risks.
• Patients should inform their doctor of any heart conditions before use.

PHARMACOLOGY, Metabolism and ExcretionWARNINGS and PRECAUTIONS).

Aspect	Details	Notes
Legal Status	Prescription-only medication	Requires a doctor’s prescription
Availability	Widely available in pharmacies globally	Also accessible via online pharmacies
Prescription Requirements	Medical evaluation needed before purchase	Ensures safe and proper use
Generic Versions	Available in some markets	May be less expensive
Regulatory Agencies	Approved by FDA (USA), EMA (Europe), other national agencies	Ensures safety and efficacy standards

Renal Impairment: For patients with mild

Aspect	Details	Notes
Storage Temperature	Between 15°C and 30°C	Keep away from heat and moisture
Keep Out of Reach of Children	Yes	To prevent accidental ingestion
Storage Conditions	Store in original packaging, away from direct sunlight	Maintain stability and potency
Expiry Date	Usually 3 years from manufacturing date	Do not use expired medication
Handling Precautions	Avoid crushing or splitting tablets	Follow prescribed instructions

(CLcr = 50-80 ml/min), moderate (CLcr =

Product	Dosage	Quantity + Bonus	Price
Levitra Generic	10mg	360 + 10 Pills	407.94€ 388.51€	Buy
Levitra Original	20mg	64 + 4 Pills	298.45€ 284.24€	Buy
Levitra Generic	10mg	30 + 4 Pills	62.39€ 59.42€	Buy
Levitra Soft Tabs	20mg	180 + 10 Pills	398.14€ 379.18€	Buy
Levitra Generic	20mg	10 Pills	31.49€ 29.99€	Buy
Levitra Generic	40mg	180 + 10 Pills	405.06€ 385.77€	Buy
Levitra Generic	40mg	10 Pills	41.37€ 39.40€	Buy
Levitra Professional	20mg	30 Pills	119.12€ 113.45€	Buy
Levitra Generic	20mg	30 + 4 Pills	70.59€ 67.23€	Buy
Levitra Professional	20mg	360 + 6 Pills	914.63€ 871.08€	Buy
Levitra Soft Tabs	20mg	60 + 4 Pills	178.40€ 169.90€	Buy

30-50 ml/min), or severe (CLcr<30 ml/min)

¿Cómo debo utilizar vardenafil?

Phase 3 clinical trials included more than 834 elderly patients, and no differences in safety or effectiveness of LEVITRA 5, 10, or 20 mg were noted when these elderly patients were compared to younger patients. However, due to increased vardenafil concentrations in the elderly, a starting dose of 5 mg LEVITRA should be considered in levitra no prescription online patients ≥65 years of age. LEVITRA was administered to over 4430 men (mean age 56, range 18-89 years; 81% White, 6% Black, 2% Asian, 2% Hispanic and 9% Other) during controlled and uncontrolled clinical trials worldwide. Over 2200 patients were treated for 6 months or longer, and 880 patients were treated for at least 1 year. In placebo-controlled clinical trials, the discontinuation rate due to adverse events was 3.4% for LEVITRA compared to 1.1% for placebo.

Bayer Savings Card

When LEVITRA was taken as recommended in placebo-controlled clinical trials, the following adverse events were reported (see Table 5). Back pain was reported in 2.0% of patients treated with LEVITRA and 1.7% of patients on placebo. Placebo-controlled trials suggested a dose effect in the incidence of some adverse events (headache, flushing, dyspepsia, nausea, rhinitis) over the 5 mg, 10 mg, and 20 mg doses of LEVITRA. The following section identifies additional, less frequent events (<2%) reported during the clinical development of LEVITRA. Excluded from this list are those events that are infrequent and minor, those events that may be commonly observed in the absence of drug therapy, and those events that are not reasonably associated with the drug. renal impairment, no dose adjustment is required.

Uso clínico

Other interactions: LEVITRA had no effect on the pharmacodynamics of glyburide (glucose and insulin concentrations) and warfarin (prothrombin time or other pharmacodynamic parameters). Vardenafil was not carcinogenic in rats and mice when administered daily for 24 months. In these studies systemic drug exposures (AUCs) for unbound (free) vardenafil and its major metabolite were approximately 400- and 170-fold for male and female rats, respectively, and 21- and 37-fold for male and female mice, respectively, the exposures observed in human males given the Maximum Recommended Human Dose (MRHD) of 20 mg. Vardenafil was not mutagenic as assessed in either the in vitro bacterial Ames assay or buy levitra no prescription the forward mutation assay in Chinese hamster V79 cells. Vardenafil did not impair fertility in male and female rats administered doses up to 100 mg/kg/day for 28 days prior to mating in male, and for 14 days prior to mating and through day 7 of gestation in females.

What should I do if I miss a dose of vardenafil?

In a corresponding 1-month rat toxicity study, this dose produced an AUC value for unbound vardenafil 200 fold greater than AUC in humans at the MRHD of 20 mg. There was no effect on sperm motility or morphology after single 20 mg oral doses of vardenafil in healthy volunteers. LEVITRA is not indicated for use in women, newborns, or children. Vardenafil was secreted into the milk of lactating rats at concentrations approximately 10-fold greater than found in the plasma. Following a single oral dose of 3 mg/kg, 3.3% of the administered dose was excreted into the milk within 24 hours.